Adicet Bio appoints Dr. Lloyd Klickstein to its Board, effective August 19, 2024

Adicet Bio, Inc.

Dr. Michael Kauffman resigned from Board and Nominating Committee effective Aug 19, 2024; no disagreement cited.
Dr. Lloyd Klickstein, M.D., Ph.D., appointed as Class III director and to Nominating Committee; term through 2027 annual meeting.
Klickstein received an option for 70,200 shares, vesting over 36 months, plus standard non-employee director compensation.
Klickstein previously served as Adicet's Chief Innovation Officer and has leadership experience at Novartis and Eli Lilly.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Kauffman

Director

ACET · Adicet Bio, Inc.

Effective: 2024-08-19
Successor: Lloyd Klickstein
Filed: August 19, 2024, 7:59 PM ET

Michael Kauffman, M.D., Ph.D., a Class III member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Nominating and Corporate Governance Committee (the “NCG Committee”), effective as of August 19, 2024.

Appointed

Lloyd Klickstein

Director

ACET · Adicet Bio, Inc.

Effective: 2024-08-19
Filed: August 19, 2024, 7:59 PM ET

the Board appointed Lloyd Klickstein, M.D., Ph.D. to the Board, effective as of August 19, 2024, to fill the vacancy on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Kauffman resigned as Director at Adicet Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

Michael Kauffman, M.D., Ph.D., a Class III member of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), notified the Company of his resignation from the Board and Nominating and Corporate Governance Committee (the “NCG Committee”), effective as of August 19, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lloyd Klickstein was appointed as Director at Adicet Bio, Inc..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Lloyd Klickstein, M.D., Ph.D. to the Board, effective as of August 19, 2024, to fill the vacancy on the Board.

View on SEC.gov

Adicet Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-098485

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.